|
|
Allegra (Fexofenadine HCI)
|
 |
Respiratory agent
|
 |
Antihistamine
|
 |
The relief of symptoms associated with seasonal Allergic Rhinitis in adults and children 12 years of age and older.
|
 |
The recommended dose of fexofenadine HCl is 60 mg twice daily for adults and children 12 years of age and older.
|
 |
Category C
|
 |
Cold, flu, nausea, fatigue, dysmenorrhea, dyspepsia, drowsiness, and upset stomach.
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
|
|
 |
|
|
|
|
under which this service is provided to you. Read our
.
Copyright © 2002 - 2003 eCureMe, Inc All right reserved.
|
 |
|
 |
|
|
